Heterogeneous intracellular TRAIL-receptor distribution predicts poor outcome in breast cancer patients.

导出原文传递

翻译打印收藏纠错

第一作者： Thorsten,Heilmann

第一单位： Department of Gynecology and Obstetrics, University Hospital Schleswig-Holstein, Kiel, Germany.

作者： Thorsten,Heilmann ^[1] ; Florian,Vondung ^[2] ; Christoph,Borzikowsky ^[3] ; Silke,Szymczak ^[3] ; Sandra,Krüger ^[2] ; Ibrahim,Alkatout ^[1] ; Antonia,Wenners ^[1] ; Maret,Bauer ^[4] ; Wolfram,Klapper ^[5] ; Christoph,Röcken ^[2] ; Nicolai,Maass ^[2] ; Silvia,von Karstedt ^[1] ; Christian,Schem ^[6] ; Anna,Trauzold ^[7]

作者单位： Department of Gynecology and Obstetrics, University Hospital Schleswig-Holstein, Kiel, Germany. ^[1] Department of Pathology, General Pathology and Hematopathology, University Hospital Schleswig-Holstein, Kiel, Germany. ^[2] Institute of Medical Informatics and Statistics, Christian-Albrechts-University of Kiel, Kiel, Germany. ^[3] Fertility Center Kiel, Kiel, Germany. ^[4] Frauenpraxis Ostufer, Kiel, Germany. ^[5] Department of Translational Genomics, University Hospital Cologne, Cologne, Germany. ^[6] Excellence Cluster on Cellular Stress Response in Aging-Associated Diseases (CECAD), University of Cologne, Cologne, Germany. ^[7] Mammazentrum am Krankenhaus Jerusalem, Hamburg, Germany. ^[8] Institute for Experimental Cancer Research, Christian-Albrechts-University of Kiel, Arnold-Heller Str. 3 (Haus 17), 24105, Kiel, Germany. atrauzold@email.uni-kiel.de. ^[9]

关键词 Breast cancer Molecular marker TRAIL TRAIL-receptor TRAIL-receptor interaction